Part Details | DOXYCYLINE FOR INJECTION
6505-01-516-7604
Alternate Parts: NDC63323013011, NDC63323-0130-11, 040011, 04-0011, NDC55390011010, NDC55390-0110-10, 6505-01-516-7604, 01-516-7604, 6505015167604, 015167604
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 20, 2004 | 01-516-7604 | 66674 ( DOXYCYLINE FOR INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-516-7604
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC63323-0130-11 | 1DQP2 | AMERICAN PHARMACEUTICAL PARTNERS |
| 04-0011 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC55390-0110-10 | 4LQT5 | VETERANS HEALTH |
Technical Data | NSN 6505-01-516-7604
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB100.000 MILLIGRAMS DOXYCYCLINE HYCLATE |
| PHYSICAL FORM | POWDER |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLIGRAMS |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| SPECIAL FEATURES | EACH VIAL CONTAINS DOXYCYCLINE HYCLATE EQUIVALENT TO 100 MG DOXYCYCLINE AND 480 MG ASCORBIC ACID; DOYXCYCLINE IS PRIMARILY BACTERIOSTATIC AND THROUGHT TO EXERT ITS ANTIMICROBIAL EFFECT BY THE INHIBITION OF PROTEIN SYNTHESIS; DOXYCYCLINE IS ACTIVE AGAINST A WIDED RANGE OF GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DOXYCYCLINE HYDROCHLORIDE INJECTION (10) VIAL PER PACKAGE |